Published in Mol Cell Neurosci on April 24, 2014
Gene therapy and peripheral nerve repair: a perspective. Front Mol Neurosci (2015) 0.84
High cerebrospinal fluid levels of interleukin-10 attained by AAV in dogs. Gene Ther (2014) 0.76
In vivo dynamics of AAV-mediated gene delivery to sensory neurons of the trigeminal ganglia. Sci Rep (2017) 0.75
Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods (1994) 23.05
Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med (2011) 11.01
Clades of Adeno-associated viruses are widely disseminated in human tissues. J Virol (2004) 7.12
Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A (1994) 6.61
Chronic catheterization of the spinal subarachnoid space. Physiol Behav (1976) 6.16
Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science (2003) 4.52
New recombinant serotypes of AAV vectors. Curr Gene Ther (2005) 3.87
Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology (2008) 2.80
The AAV vector toolkit: poised at the clinical crossroads. Mol Ther (2012) 2.53
Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale. Hum Gene Ther (2010) 2.51
Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther (2012) 2.42
Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents. J Neurosurg (2005) 2.07
Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain. Mol Ther (2008) 2.06
Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector. Mol Ther (2011) 2.04
Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain. Mol Ther (2003) 1.94
Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain. Proc Natl Acad Sci U S A (2008) 1.73
Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates. Gene Ther (2013) 1.73
Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain. Hum Gene Ther (2006) 1.72
Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease. Hum Gene Ther (2012) 1.70
A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's disease. Mol Ther (2010) 1.68
Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. Mol Ther (2009) 1.66
Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery. Hum Gene Ther (2011) 1.53
Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates. Hum Gene Ther (2013) 1.52
The human visual cortex responds to gene therapy-mediated recovery of retinal function. J Clin Invest (2011) 1.52
Efficient retrograde neuronal transduction utilizing self-complementary AAV1. Mol Ther (2007) 1.51
Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs. Gene Ther (2011) 1.47
Perineurial defect and peripheral opioid analgesia in inflammation. J Neurosci (1995) 1.45
Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery. Mol Pain (2009) 1.39
Direct convective delivery of macromolecules to peripheral nerves. J Neurosurg (1998) 1.35
Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain. J Virol (2002) 1.30
Optimized cannula design and placement for convection-enhanced delivery in rat striatum. J Neurosci Methods (2009) 1.25
Intrathecal catheterization and drug delivery in the rat. Methods Mol Med (2004) 1.24
Segmental spinal nerve ligation model of neuropathic pain. Methods Mol Med (2004) 1.24
Long-term follow-up after gene therapy for canavan disease. Sci Transl Med (2012) 1.22
Efficiencies of transgene expression in nociceptive neurons through different routes of delivery of adeno-associated viral vectors. Hum Gene Ther (2003) 1.21
Intrathecal long-term gene expression by self-complementary adeno-associated virus type 1 suitable for chronic pain studies in rats. Mol Pain (2006) 1.11
Ultrasound imaging for regional anesthesia in infants, children, and adolescents: a review of current literature and its application in the practice of extremity and trunk blocks. Anesthesiology (2010) 1.10
Differential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture. Mol Pain (2010) 1.09
An evaluation of the relationships between catheter design and tissue mechanics in achieving high-flow convection-enhanced delivery. J Neurosci Methods (2011) 1.08
AAV8(gfp) preferentially targets large diameter dorsal root ganglion neurones after both intra-dorsal root ganglion and intrathecal injection. Mol Cell Neurosci (2012) 1.07
Interventional therapy of head and neck cancer with lipid nanoparticle-carried rhenium 186 radionuclide. J Vasc Interv Radiol (2010) 1.04
Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosis. Hum Gene Ther Methods (2012) 1.01
Basic fibroblast growth factor enhances transduction, distribution, and axonal transport of adeno-associated virus type 2 vector in rat brain. Hum Gene Ther (2004) 1.00
Schwann cell targeting via intrasciatic injection of AAV8 as gene therapy strategy for peripheral nerve regeneration. Gene Ther (2011) 0.99
Gene therapy for the peripheral nervous system: a strategy to repair the injured nerve? Curr Gene Ther (2011) 0.94
Design of an in-dwelling cannula for convection-enhanced delivery. J Neurosci Methods (2010) 0.93
Monitoring during peripheral nerve blockade. Curr Opin Anaesthesiol (2010) 0.89
Anesthetic efficacy of combinations of 0.5 mol/L mannitol and lidocaine with epinephrine for inferior alveolar nerve blocks in patients with symptomatic irreversible pulpitis. J Endod (2012) 0.89
Anesthetic efficacy of combinations of 0.5 m mannitol and lidocaine with epinephrine in inferior alveolar nerve blocks: a prospective randomized, single-blind study. Anesth Prog (2011) 0.88
Convection-enhanced delivery in intact and lesioned peripheral nerve. J Neurosurg (2001) 0.87
Targeted drug delivery to the peripheral nervous system using gene therapy. Neurosci Lett (2012) 0.86
Gene therapy for peripheral nervous system diseases. Curr Gene Ther (2007) 0.85
AAV provides an alternative for gene therapy of the peripheral sensory nervous system. Mol Ther (2010) 0.84
In vivo contrast-enhanced MR imaging of direct infusion into rat peripheral nerves. Ann Biomed Eng (2011) 0.76